跳至主要内容
临床试验/CTRI/2024/03/064565
CTRI/2024/03/064565尚未招募不适用

Comparison of analgesic efficacy (intra and post operatively) of ultrasound guided Erector spinae plane block, Serratus anterior plane block, Paravertebral plane block and intravenous opioids for modified radical mastectomy- A prospective randomised controlled trial

NARAYANA HRUDHAYALAYA1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2024年4月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
44
试验地点
1
主要终点
To document and compare cumulative opioid consumption intraoperatively and 24 hours postoperatively in all 4 groups

研究概览

简要总结

Post-mastectomy pain is a big problem affecting the outcome of surgery which is usually managed by analgesics associated with side effects such as nausea, vomiting, sedation and respiratory depression. Therefore, for effective pain control with minimal side effects, many regional analgesic techniques have been developed which have better hemodynamic stability, early ambulation, reduced hospital stay duration postoperatively. This current study will be undertaken to compare the effectiveness of 3 techniques Erector Spinae plane block (ESPB), Serratus anterior plane block (SAPB) and Paravertebral plane block (PVPB) with intravenous analgesics especially opioids being control group following breast surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
Female

入选标准

  • 1.More than 18 years with breast cancer 2.American society of anesthesiologists physical status I to III.
  • 3.patients who have given informed written consent.

排除标准

  • Body mass index more than 40 Local anaesthetic allergy Local infection at the site of block Respiratory or neurological disease.

结局指标

主要结局

To document and compare cumulative opioid consumption intraoperatively and 24 hours postoperatively in all 4 groups

时间窗: To document and compare cumulative opioid consumption intraoperatively and 24 hours postoperatively in all 4 groups

次要结局

  • 1.Time of first rescue analgesic(2.Interval between opioid doses.)

研究者

发起方
NARAYANA HRUDHAYALAYA
申办方类型
Private hospital/clinic
责任方
Principal Investigator
主要研究者

DrDIVYA DHARSHINIVP

NARAYANA HRUDHAYALAYA LTD.

研究点 (1)

Loading locations...

相似试验